Login to Your Account



Other News To Note


Thursday, March 10, 2011
• ViroPharma Inc., of Exton, Pa., said its board authorized the use of up to $150 million to repurchase shares of its common stock and/or its 2 percent senior convertible notes due 2017.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription